Retatrutide - 15MG [Triple GLP-1/GIP/Glucagon Receptor Agonist]

Also searched as: Reta Peptide, R3ta, Reda Peptide, Ratatouille Peptide

Retatrutide is searched under several alternate spellings. In the research literature it is commonly shortened to Reta peptide or Reta. The numeric form R3ta peptide also appears in online research communities. Two frequent autocorrect misspellings are Reda peptide and Ratatouille peptide — all refer to the same triple-agonist research compound.

Triple GLP-1/GIP/Glucagon Receptor Agonist

Retatrutide is a tri-agonist research peptide studied for its effects on fat metabolism, appetite regulation, and energy expenditure. Supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

Key Research Areas

• Fat Loss Research — including visceral adiposity
• Appetite Regulation — reduced food intake and caloric studies
• Metabolic Markers — blood pressure, lipids, waist circumference
• Energy Expenditure — via glucagon receptor activation
• Comparative Research — studied alongside semaglutide and tirzepatide

Supplied as lyophilized powder at 99.216% purity as reported on the CoA, verified by HPLC and mass spectrometry. 15mg per vial. Fast domestic shipping across Australia..

⚠ For in-vitro research and laboratory use only. Not for human consumption.